Previous 10 | Next 10 |
2023-05-24 09:00:00 ET Summary This year, so far, dividend investors are dealing with underperformance as the market has shifted from value to growth stocks. This is amplified by economic growth fears. While underperformance isn't fun, weakness comes with opportunities, which is w...
2023-05-24 05:39:50 ET Summary Danaher has demonstrated very steady growth in financial metrics over the decade with very solid free cash flows. The company is experiencing headwinds to continue growth given the harsh macro environment. Also, my valuation analysis shows the co...
2023-05-24 03:54:53 ET Summary Generation Investment Management’s 13F portfolio value increased from $17.32B to $18.78B this quarter. They increased Microsoft Corporation, Thermo Fisher Scientific, Texas Instruments, and Palo Alto Networks while decreasing Charles Schwab, T...
2023-05-23 10:05:28 ET Summary Danaher is now down over 30% from its all-time high in 2021. The life-science giant is seeing huge growth opportunities in the large and fast-growing bioprocessing market. The overhang from COVID and the decline in R&D activities should prese...
2023-05-23 07:39:57 ET Goldman Sachs is more bullish on the U.S. economy than the rest of Wall Street. But its equity team has a list of stocks in case a hard landing from the tightening cycle materializes. Goldman's economists put the chance of a recession at 35%, compared with the Wal...
2023-05-23 05:12:34 ET Summary Akre Capital Management’s 13F portfolio value increased from $11.06B to $11.37B this quarter. They decreased CarMax substantially this quarter. The top three positions are Mastercard, Moody’s, and American Tower and they add up to ~...
2023-05-23 05:09:49 ET Summary Thanks to its business model, Danaher has managed to reach operational excellence. Solid tailwinds will back up the company to continue its compounding path. The decrease in Covid-related sales has dropped the stock price and could be an excellen...
2023-05-19 15:43:31 ET Summary I just trimmed my Apple Inc. stake. Apple's dividend growth is disappointing. I bought 12 blue chip dividend growers with the proceeds. I made the biggest trade of my life in early May. As many of you know, Apple Inc. ( AAPL ...
2023-05-18 01:10:00 ET Summary Earnings season has been better than feared, and we highlight two firms offering differing views on the state of the economy. There’s also one falling Pharma company that (once again) delayed its Q3 results. Broadly, our data show solid di...
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2023) - Discovery Harbour Resources Corp. (TSXV: DHR) (OTC Pink: DCHRF) (FSE: 4GW) (the " Company " or " Discovery Harbour ") announces that it intends to complete a consolidation of its issued and outstanding common shares (the " Shares ")...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...